Global Vocal Fold Augmentation Market - 2022-2029

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,350	167 Pages	DataM Intelligence 4Market Research LLP	February, 2025	DTAM19614294

Best Price Guarantee
Price	from $4,350
Length	167 Pages
Publisher	DataM Intelligence 4Market Research LLP
Published Date	February, 2025
SKU	DTAM19614294

Vocal Fold Augmentation The Global Vocal Fold Augmentation Market reached US$ 2,042.8 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 2,642.8 million by 2031. The vocal fold augmentation market is expected to exhibit a CAGR of 3.3% during the forecast period 2024-2031.

According to the article published in the Journal of Voice in 2022, Vocal fold paresis or paralysis (VFP) may severely affect the quality of life due to dysphonia and respiratory distress as an increasing percentage of the U.S. population receives the COVID-19 vaccination. Vocal cord augmentation is a procedure used to treat glottis insufficiency, a condition that prevents the vocal cords from closing completely, leading to a weak or quiet voice.

The global vocal fold augmentation market is driven by factors such as increasing awareness of voice disorders, growing demand for minimally invasive procedures and advancements in technology. The market is expected to continue to grow in the coming years, as the prevalence of voice disorders increases and new products and procedures are developed.

Vocal Fold Augmentation Market Trends

The Rising Use of Vocal Fold Injection (vfi) for Laryngeal Disorders is Driving the Market Growth

Vocal fold injection (VFI) has re-emerged as a valuable treatment modality for a variety of laryngeal disorders. This procedure involves injecting a substance, such as hyaluronic acid or calcium hydroxylapatite, into the vocal folds to improve their function and reduce symptoms of voice disorders.

There are several reasons for the increasing use of VFI. First, the procedure is relatively simple and can be performed on an outpatient basis, which makes it more convenient for patients and reduces healthcare costs compared to more invasive surgical procedures.

Second, VFI can be used to treat a variety of voice disorders, including vocal fold paralysis, vocal fold atrophy and vocal fold nodules, among others. This versatility makes VFI an attractive option for many patients and healthcare providers. Therefore, owing to these reasons, the global vocal fold augmentation market is expected to have a boost over the forecast period.

The Growing Geriatric Population Will Create Lucrative Opportunities for Global Vocal Fold Augmentation Market Growth

The growing geriatric population, which is more prone to such diseases as cancer, will propel the global vocal fold augmentation market growth. According to a report by The World Health Organization (WHO) in 2022, by 2030, 1 in 6 of the world's population will be 60 years or older, with the number of individuals in this age group increasing from 1 billion in 2020 to 1.4 billion. Additionally, by 2050, the global population of people aged 60 years and above is expected to double to 2.1 billion.

As in laryngeal cancer, the surgery to remove cancerous tissue from the larynx can result in vocal fold scarring or damage, which can lead to voice disorders. Vocal fold augmentation procedures may be used to restore voice function and improve the quality of life for patients who experience these types of voice changes.

The Inflammatory Complications of Vocal Fold Injection With Hyaluronic Acid Will Inhibit the Market Growth

Hyaluronic acid (HA) is frequently used in injection laryngoplasty due to its simple injection procedure and ability to promote tissue regeneration by attracting fibroblasts, facilitating collagen deposition, and enhancing the viscoelasticity of the injected tissues. Despite its popularity as an injectable material, there have been reports of inflammatory adverse reactions following HA injections into the vocal folds. This could have a negative impact on the global vocal fold augmentation market.

Vocal Fold Augmentation Market Segmentation Analysis

The global vocal fold augmentation market is segmented based on material type, treatment type, end user and region.

The Carboxymethylcellulose Segment is Expected to Dominate the Global Vocal Fold Augmentation Market.

In the material type segment, the carboxymethylcellulose segment is expected to account for the highest market share of about 30.7% over the forecast period. Carboxymethylcellulose (CMC) is a thickening agent made by reacting cellulose (wood pulp, cotton lint) with a derivative of acetic acid (the acid in vinegar)., also called cellulose gum.

Carboxymethylcellulose and cross-linked hyaluronic acid gels are commonly used as temporary or resorbable injectable materials for vocal fold medialization, such as in Radiesse voice gel. These injections are used for temporary vocal fold paralysis and trial vocal fold injection augmentation for a variety of causes of glottic incompetence. As a result, the carboxymethylcellulose vocal cord injections market is expected to grow steadily in the forecast period.

Vocal Fold Augmentation Market Geographical Share

North America to Dominate the Global Vocal Fold Augmentation Market

North America is expected to hold a dominant position in the global vocal fold augmentation market clinching 2/5th share of the total market, owing to the factors such as the growing vocal & respiratory-related disorders and the presence of major players in the region.

For instance, as per the article published in the Journal of Voice in 2022, Vocal fold paresis or paralysis (VFP) may severely affect the quality of life due to dysphonia and respiratory distress as an increasing percentage of the United States population receives the COVID-19 vaccination.

Voice disorders are a common problem in the U.S., affecting millions yearly. The exact prevalence of voice disorders is difficult to determine, but it is estimated that approximately 9% of the population experiences a voice disorder at some point in their lives, thereby contributing to the growth of the vocal fold augmentation market in North America throughout the forecast period.

Vocal Fold Augmentation Companies

The major global players in the market include Merz Holding GmbH & Co KG (Merz Pharmaceuticals, LLC), Sofregen Medical Inc., Hoya Corporation(PENTAX Medical America, Inc.), SPIGGLE & THEIS Medizintechnik GmbH, Inhealth Technologies, APrevent Medical Inc., Boston Medical Products, Inc., among others.

COVID-19 Impact on Vocal Fold Augmentation Market

The COVID-19 pandemic has caused disruptions in the global vocal fold augmentation market due to disruptions in the supply chain and manufacturing of medical devices and equipment, leading to delays and shortages. Additionally, healthcare facilities have reduced elective procedures, including vocal fold augmentation surgeries, due to the overwhelming number of COVID-19 patients.

Despite the negative impact, the market is expected to recover as the pandemic situation improves, driven by the growing prevalence of voice disorders and the development of innovative surgical techniques and new product launches in the market. However, the long-term impact of the pandemic on the market remains to be seen.

Russia-Ukraine Conflict Analysis

The ongoing Russia-Ukraine War could indirectly impact the Vocal Fold Augmentation market by disrupting the manufacturing and distribution channels, leading to supply shortages and higher product costs that may affect smaller companies. Despite these challenges, the market is expected to grow in the long term due to rising healthcare awareness and the increasing prevalence of voice-related disorders.

This is expected to create growth opportunities for companies in the industry. While the war's impact, combined with the ongoing pandemic, may cause short-term disruptions, the market is expected to recover and continue to grow in the long term. Therefore, it is important to monitor the conflict's impact on the global healthcare industry as a whole.

Key Developments
• In August 2022, InHealth Technologies, a business unit of Freudenberg Medical, launched the Blom-Singer Day&Night HME device in the United States. This device is intended for people who have undergone total laryngectomy and is designed for comfortable all-day and all-night use, including during bedtime. The device is a single-use heat and moisture exchange (HME) and is compatible with the entire family of InHealth products.
• In December 2021, Scientists at McGill University developed a biomaterial hydrogel that can be used to repair heart, muscle, and vocal cord tissues. The synthetic material can be injected into the body and provides space for cells to live and grow.
• In October 2020, PENTAX Medical, a leader in diagnostic and therapeutic endoscopy solutions, entered into a distribution agreement with Sofregen Medical Inc. for its Silk Voice Injectable Implant. As part of the agreement, PENTAX Medical will be the sole sales agent for Silk Voice in the United States.

Why Purchase the Report?
• To visualize the global vocal fold augmentation- market segmentation based on material type, treatment type, end user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of global vocal fold augmentation market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The Global Vocal Fold Augmentation Market Report Would Provide Approximately 53 Tables, 54 Figures and 195 Pages.

Target Audience 2024
• Manufacturers / Buyers
• Industry Investors/Investment Bankers
• Research Professionals

1. Methodology and Scope: 1.1. Research Methodology; 1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary: 3.1. Snippet by Material Type; 3.2. Snippet by Treatment Type; 3.3. Snippet by End-User; 3.4. Snippet by Region
4. Dynamics: 4.1. Impacting Factors; 4.1.1. Drivers; 4.1.1.1. Rising use of vocal fold injection (vfi) for laryngeal disorders is driving market growth.; 4.1.2. Restraints; 4.1.2.1. Th growing geriatric population will create lucrative opportunities for global vocal fold augmentation market growth.; 4.1.3. Opportunity; 4.1.3.1. The inflammatory complications of vocal fold injection with hyaluronic acid will inhibit the market growth.; 4.1.4. Impact Analysis
5. Industry Analysis: 5.1. Porter's Five Forces Analysis; 5.2. Supply Chain Analysis; 5.3. Pricing Analysis; 5.4. Regulatory Analysis
6. COVID-19 Analysis: 6.1. Analysis of COVID-19; 6.1.1. Before COVID-19 Scenario; 6.1.2. Present COVID-19 Scenario; 6.1.3. Post COVID-19 or Future Scenario; 6.2. Pricing Dynamics Amid COVID-19; 6.3. Demand-Supply Spectrum; 6.4. Government Initiatives Related to the Market During the Pandemic; 6.5. Manufacturers’ Strategic Initiatives; 6.6. Conclusion
7. By Material Type: 7.1. Introduction; 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type; 7.1.2. Market Attractiveness Index, By Material Type; 7.2. Carboxymethylcellulose; 7.2.1. Introduction; 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%); 7.3. Calcium Hydroxylapatite; 7.4. Hyaluronic Acid; 7.5. Silk; 7.6. Gelfoam; 7.7. Fats; 7.8. Others
8. By Treatment Type: 8.1. Introduction; 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type; 8.1.2. Market Attractiveness Index, By Treatment Type; 8.2. Temporary; 8.2.1. Introduction; 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%); 8.3. Permanent
9. By End User: 9.1. Introduction; 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User; 9.1.2. Market Attractiveness Index, By End User; 9.2. Hospitals*; 9.2.1. Introduction; 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%); 9.3. Specialty Clinics; 9.4. Others
10. By Region: 10.1. Introduction; 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region; 10.1.2. Market Attractiveness Index, By Region; 10.2. North America; 10.2.1. Introduction; 10.2.2. Key Region-Specific Dynamics; 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type; 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type; 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User; 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 10.2.6.1. The U.S.; 10.2.6.2. Canada; 10.2.6.3. Mexico; 10.3. Europe; 10.3.1. Introduction; 10.3.2. Key Region-Specific Dynamics; 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type; 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type; 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User; 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 10.3.6.1. Germany; 10.3.6.2. UK; 10.3.6.3. France; 10.3.6.4. Italy; 10.3.6.5. Spain; 10.3.6.6. Rest of Europe; 10.4. South America; 10.4.1. Introduction; 10.4.2. Key Region-Specific Dynamics; 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type; 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type; 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User; 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 10.4.6.1. Brazil; 10.4.6.2. Argentina; 10.4.6.3. Rest of South America; 10.5. Asia-Pacific; 10.5.1. Introduction; 10.5.2. Key Region-Specific Dynamics; 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type; 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type; 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User; 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country; 10.5.6.1. China; 10.5.6.2. India; 10.5.6.3. Japan; 10.5.6.4. Australia; 10.5.6.5. Rest of Asia-Pacific; 10.6. Middle East and Africa; 10.6.1. Introduction; 10.6.2. Key Region-Specific Dynamics; 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material Type; 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Treatment Type; 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11. Competitive Landscape: 11.1. Competitive Scenario; 11.2. Market Positioning/Share Analysis; 11.3. Mergers and Acquisitions Analysis
12. Company Profiles: 12.1. Merz Holding GmbH & Co KG (Merz Pharmaceuticals, LLC) *; 12.1.1. Company Overview; 12.1.2. Product Portfolio and Description; 12.1.3. Financial Overview; 12.1.4. Key Developments; 12.2. Sofregen Medical Inc.; 12.3. Hoya Corporation (PENTAX Medical America, Inc.); 12.4. SPIGGLE & THEIS Medizintechnik GmbH; 12.5. Inhealth Technologies; 12.6. APrevent Medical Inc.; 12.7. Boston Medical Products, Inc. (*LIST NOT EXHAUSTIVE)
13. Appendix: 13.1. About Us and Services; 13.2. Contact Us